SUNRISE TECHNOLOGIES INTERNATIONAL INC
10-Q, 1996-05-14
DENTAL EQUIPMENT & SUPPLIES
Previous: SPECIALTY RETAILERS INC /DE/, 8-K, 1996-05-14
Next: MADISON BANCSHARES GROUP LTD, 10QSB, 1996-05-14




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
              -----------------------------------------------------

                                    FORM 10-Q


 [X]     Quarterly  report  pursuant  to  Section  13 or 15(d) of the Securities
         Exchange Act of 1934 for the quarter  ended  March 31, 1996 or



 [ ]     Transition  report  pursuant  to  Section 13 or 15(d) of the Securities
         Exchange  Act  of  1934  (no  fee  required)  for the transition period
         from _______________ to _______________.


                           Commission File No. 0-17816


                    Sunrise Technologies International, Inc.
             (Exact name of Registrant as specified in its charter)

             Delaware                                    77-0148208
 (State or other jurisdiction of                      (I.R.S. Employer
  incorporation or organization                    Identification Number)
  
47257 Fremont Boulevard, Fremont, California                94538
  (Address of principal executive offices)                (Zip Code)

       Registrant's telephone number, including area code: (510) 623-9001



Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                                  Yes X   No 
                                     ----    ----


There were 25,356,510 of the Registrant's Common Stock issued and outstanding on
April 22, 1996.


<PAGE>



                                      INDEX

<TABLE>

                    SUNRISE TECHNOLOGIES INTERNATIONAL, INC.



<CAPTION>
                                                                                                         PAGE
<S>                                                                                                       <C>

PART I.  FINANCIAL INFORMATION

Item  1. Financial Statements (unaudited)

            Consolidated Statements of Operations--Three months ended March 31, 1996 and 1995             1

            Consolidated Balance Sheets--March 31, 1996 and December 31, 1995                             2

            Consolidated Statements of Cash Flows--Three months ended March 31, 1996 and 1995             3

            Notes to consolidated financial statements--March 31, 1996                                    4


Item  2. Management's Discussion and Analysis of Financial Condition and Results of Operations            5


PART II. OTHER INFORMATION

Item  6. Exhibits and Reports on Form 8-K                                                                 7


SIGNATURES                                                                                                8
</TABLE>

                                        i

<PAGE>



PART I.  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

<TABLE>
                    SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

                      Consolidated Statements of Operations
                                   (unaudited)


<CAPTION>
                                                            Three months ended March 31,
                                                             1996                1995
                                                --------------------------------------------------
                                                        (In thousands, except per share amounts)

<S>                                                      <C>                  <C>

Net revenues                                               $1,521              $2,139
Cost of revenues                                            1,139               1,209
                                                --------------------------------------------------
Gross profit                                                  382                 930

Other costs and expenses:
      Engineering and development                             175                 116
      Sales, marketing and regulatory                       1,114                 901
      General and administrative                              567                 462

         Total other costs and expenses                     1,856               1,479
                                                --------------------------------------------------

Loss from operations                                       (1,474)               (549)
      Interest income                                          31                  --
                                                --------------------------------------------------

         Net loss                                         $(1,443)              $(549)
                                                ==================================================

Net loss per share                                         $(0.06)             $(0.05)
                                                ==================================================
      Shares used in calculation of
      net loss per share                                   25,315              10,184
                                                ==================================================





<FN>
                             See accompanying notes.
</FN>
</TABLE>


                                        1

<PAGE>

<TABLE>

SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

                           Consolidated Balance Sheets
<CAPTION>

                                                             March 31,        December 31,
                                                                1996              1995
                                                         ----------------------------------
                                                            (unaudited)          (note)
                                                                    (In thousands)
<S>                                                            <C>               <C>

                         Assets
Current assets:
  Cash and cash equivalents                                    $1,452            $3,514
  Accounts receivable, net of allowance                         1,246             1,048
  Inventories                                                   2,633             1,666
  Prepaid expenses                                                240               257
                                                         ----------------------------------
       Total current assets                                     5,571             6,485

Property and equipment, net                                       189               204
                                                         ----------------------------------
Total assets                                                   $5,760            $6,689
                                                         ==================================

          Liabilities and stockholders' equity
Current liabilities:
  Accounts payable                                             $1,518            $1,097
  Accrued payroll and related expenses                            210               181
  Accrued warranty                                                324               324
  Other accrued expenses                                          332               342
                                                         ----------------------------------
       Total current liabilities                                2,384             1,944

Commitments and contingencies

Stockholders' equity:
  Preferred stock, $0.001 par value, 2,000,000 shares
    authorized, none issued or outstanding.
  Common stock, $0.001 par value,  40,000,000 shares
  authorized,  25,356,510 and  25,280,056 shares issued
  and outstanding at March 31, 1996 and
  December 31, 1995 respectively.                                  25                25
  Additional paid-in-capital                                   29,270            29,196
  Accumulated deficit                                         (25,919)          (24,476)
                                                         ----------------------------------
      Total stockholders' equity                                3,376             4,745
                                                         ----------------------------------
Total liabilities and stockholders' equity                     $5,760            $6,689
                                                         ==================================
<FN>

NOTE: The consolidated  balance sheet at December 31, 1995 has been derived from
the audited  financial  statements  at that date but does not include all of the
information and footnotes required by generally accepted  accounting  principles
for complete financial statements.


                             See accompanying notes.
</FN>
</TABLE>


                                        2

<PAGE>


<TABLE>

                    SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

                      Consolidated Statements of Cash Flows
                 Increase(decrease) in cash and cash equivalents
                                   (unaudited)

<CAPTION>
                                                             Three months ended March 31,
                                                                 1996             1995
                                                     ----------------------------------------------
                                                                     (In thousands)
<S>                                                           <C>              <C>

Cash flows from operating activities
Net loss                                                      $(1,443)          $(549)
Adjustments to reconcile net loss to net cash
    used in operating activities:
Depreciation and amortization                                      20              37
Changes in assets and liabilities:
    Accounts receivable                                          (198)           (337)
    Inventories                                                  (967)            293
    Prepaid expenses                                               17              33
    Accounts payable                                              421             318
    Accrued payroll and related expenses                           29             (40)
    Accrued warranty                                               --              --
                                                     ----------------------------------------------
    Other accrued expenses                                        (10)            129
Total adjustments                                                (688)            433
                                                     ----------------------------------------------
Net cash used in operating activities                          (2,131)           (116)
                                                     ----------------------------------------------

Cash flows from investing activities
Purchase of property and equipment                                 (5)             (8)
Purchase of short-term investments                                 --              --
                                                     ----------------------------------------------

Net cash used in investing activities                              (5)             (8)
                                                                   --              --
                                                     ----------------------------------------------

Cash flows from financing activities
Payment on capital lease obligations                               --              (4)
Issuance of common stock, net of offering costs                    74              --
Net cash provided by (used in) financing activities                74              (4)
                                                     ----------------------------------------------
   Net increase (decrease) in cash and equivalents            (2,062)            (128)
   Cash and cash equivalents at beginning of period            3,514               55
                                                     ----------------------------------------------
   Cash and cash equivalents at end of period                 $1,452             $431
                                                     ==============================================


<FN>
                             See accompanying notes.
</FN>
</TABLE>
                                        3

<PAGE>




                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)

                                 March 31, 1996



   1.    Basis of Presentation

   The consolidated financial statements include the accounts of the Company and
   its wholly-owned subsidiaries after elimination of all material  intercompany
   balances and transactions.

   The  consolidated  financial data for the quarters ended March  31,  1996 and
   1995 are unaudited,  but include all adjustments  (consisting  only of normal
   recurring   adjustments)   that  the   management  of  Sunrise   Technologies
   International,  Inc.  believes to be necessary for fair  presentation  of the
   periods presented.  Interim results are not necessarily indicative of results
   for the full year.  The financial  statements  should be read in  conjunction
   with the audited  financial  statements  for the year ended December 31, 1995
   included  in the  Company's  annual  report  on  Form  10-K  filed  with  the
   Securities and Exchange Commission.

   The Company  has  incurred  significant losses for the last several years and
   at March 31, 1996 has an accumulated  deficit of  approximately  $25,919,000.
   The accompanying  condensed financial  statements have been prepared assuming
   the Company will continue as a going concern. The Company's long term ability
   to continue as a going  concern is dependent  upon  returning  to  profitable
   operations.  Management's  plans include  increasing  sales through  expanded
   marketing  efforts  on  existing  products  and  pursuing  timely  regulatory
   approval for certain products under  development.  Management also recognizes
   the need for  infusion  of cash  during the fiscal  year 1996 and is actively
   pursuing various options including  securing  additional equity financing and
   disposing of certain  assets.  If the Company is unable to obtain  additional
   working capital  resources from the placement of debt or equity  instruments,
   or the sale of some of its assets,  it will be  necessary  for the Company to
   curtail or suspend operations.

   2.    Net Loss Per Share

   Net loss per share for the three  months  ended  March  31, 1996  and 1995 is
   based solely on weighted  average shares of common stock  outstanding  during
   the  period.  Common  equivalent  shares  have  not  been  considered  in the
   computation since their inclusion would have an antidilutive effect.

   3.    Revenue Recognition

   Revenues  are  recognized at time of shipment.  A provision for the estimated
   future cost of warranty is made at the time a sale is recorded.

   4.    Inventories

   Inventories are stated at the lower of cost  (first-in, first-out)  or market
   and consisted of the following on the dates indicated:

                                   March 31,      December 31,
                                     1996            1995
                              -------------------------------------
                                       (In thousands)
 
             Raw materials          $1,557           $909
             Work-in-process           298            237
             Finished goods            778            520
                              -------------------------------------
                                    $2,633         $1,666
                              =====================================




                                        4

<PAGE>



   5.  Income Taxes

   Due  to  the Company's losses from operations, all deferred tax assets, which
   primarily result from net operating loss carry forwards,  have been offset in
   full by a valuation allowance in accordance with SFAS No. 109.


   ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
           OF OPERATIONS

   Financial Condition

   As  of   March  31,  1996  the  Company  had  $1,452,000  in  cash  and  cash
   equivalents.  The Company's operating activities used $2,131,000 in the three
   months ended March 31, 1996 and used $4,495,000 in cash during fiscal 1995. A
   substantial  portion  of the 1995 and 1996  losses  were  funded  by the $7.5
   million net proceeds  received from the  completion of private  placements of
   15,100,000  shares of the Company's common stock at prices ranging from $0.50
   to $0.625 per share in June and September 1995.

   Working  capital  amounted  to  $4,541,000 at December 31, 1995 and decreased
   to $3,187,000 at March 31, 1996. Working capital, including the proceeds from
   the 1995 private  placements,  was used to fund the  Company's  1995 and 1996
   losses.

   The  Company's  current operations continue to be cash flow negative, further
   straining the  Company's  limited  working  capital  resources.  The level of
   current  product sales is not sufficient to provide enough cash to pursue the
   dental  business and support ongoing  development and regulatory  approval of
   the LTK system. In order to continue its current level of operations, it will
   be necessary for the Company to obtain additional  working capital resources,
   whether  from  debt or equity  sources.  If the  Company  is unable to obtain
   additional  working  capital  resources  from the placement of debt or equity
   instruments,  or the sale of some of its assets, it will be necessary for the
   Company to curtail or suspend operations.

   Results of Operations

   Revenues  of  $1,521,000  for the three months ended March 31, 1996 represent
   a 29%  decrease  from  revenues  of  $2,139,000  for the same period in 1995.
   MicroPrep,  the Company's air abrasive cavity preparation  system,  which was
   introduced in June 1994,  continues to exhibit strong customer acceptance and
   accounted  for  approximately  64% of the  Company's  revenues  for the three
   months ended March 31, 1996.  Offsetting  the MicroPrep  revenues the Company
   experienced a decrease,  internationally,  in dental laser sales in the first
   quarter.

   Gross  profit  decreased as a percentage of revenues from  approximately  43%
   for the three months ended March 31, 1995 to 25% for the same period in 1996.
   This decline is due to lower margins  associated  with the MicroPrep  product
   line vis a vis the dental laser  product line and lower  overhead  absorption
   due to the reduced level of sales.

   Engineering  and  development  expenses totaled $175,000 for the three months
   ended March 31, 1996 as compared to $116,000 for the same period in 1995.

   Sales,  marketing  and  regulatory costs were $1,114,000 for the three months
   ended March 31, 1996,  compared to $901,000 for the same period in 1995.  The
   increase  of  $213,000  reflects  the costs  associated  with a direct  sales
   organization and increased spending on marketing programs.

   General  and  administrative  expenses  were  $567,000  for  the three months
   ended  March 31,  1996,  compared  to  $462,000  for the same period in 1995.
   Increases in the principal  components of general and administrative costs of
   legal  expenses,  director  and officer  insurance  and  salaries and related
   expenses account for the change from 1995.

   The  Company  reported  a net loss for the three  months ended March 31, 1996
   of  $1,443,000,  compared  to a net loss of  $549,000  for the same period in
   1995. This decline is a result of decreased  revenues which resulted in lower
   overhead  absorption,   thus  lower  gross  margin  contribution  and  higher
   operating expenses.



                                        5

<PAGE>



   PART II  OTHER INFORMATION


   ITEM 6.  EXHIBITS AND REPORTS AND FORM 8-K.

     A.  Exhibits
          None

     B.  Report on Form 8-K
          None


                                        6

<PAGE>


                                   Signatures

   Pursuant to the  requirements  of the  Securities  Exchange Act of 1934,  the
   registrant  has duly  caused  this  report to be signed on its  behalf by the
   undersigned thereunto duly authorized.




   Date: April 22, 1996          By:   /s/ David W. Light
                                    --------------------------------------------
                                       President and Chief Executive Officer


   Date: April 22, 1996          By:   /s/ Martin D. Meeker
                                    --------------------------------------------
                                       Vice President, Finance and
                                       Chief Financial Officer



                                        7


<TABLE> <S> <C>


<ARTICLE>                         5
<MULTIPLIER>                      1,000
       
<S>                               <C>
<PERIOD-TYPE>                     3-MOS
<FISCAL-YEAR-END>                 DEC-31-1996
<PERIOD-START>                    JAN-01-1996
<PERIOD-END>                      MAR-31-1996
<CASH>                                  1,452
<SECURITIES>                                0
<RECEIVABLES>                           1,246
<ALLOWANCES>                                0
<INVENTORY>                             2,633
<CURRENT-ASSETS>                        5,571
<PP&E>                                  2,390
<DEPRECIATION>                         (2,201)
<TOTAL-ASSETS>                          5,760
<CURRENT-LIABILITIES>                   2,384
<BONDS>                                     0
<COMMON>                               29,295
                       0
                                 0
<OTHER-SE>                            (25,919)
<TOTAL-LIABILITY-AND-EQUITY>            5,760
<SALES>                                 1,521
<TOTAL-REVENUES>                        1,521
<CGS>                                   1,139
<TOTAL-COSTS>                           1,856
<OTHER-EXPENSES>                            0
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                        (31)
<INCOME-PRETAX>                        (1,443)
<INCOME-TAX>                                0
<INCOME-CONTINUING>                         0
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                           (1,443)
<EPS-PRIMARY>                           (0.06)
<EPS-DILUTED>                            0.00
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission